[The influence of aldosterone and aldosterone antagonists on the pressor effect of synthetic Angiotensin II in primary chronic adrenal cortex insufficiency (M. Addison)].
D000224:Addison Disease / Q000503:physiopathology*; D000328:Adult; D000450:Aldosterone / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids / Q000627:therapeutic use*; D011374:Progesterone / Q000494:pharmacology*; D013148:Spironolactone / Q000494:pharmacology*; D014666:Vasomotor System / Q000503:physiopathology*
D005938:Glucocorticoids; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids; D000804:Angiotensin II; D013148:Spironolactone; D000450:Aldosterone; D011374:Progesterone
Der Einfluss von Aldosteron und Aldosteron-Antagonisten auf den Pressoreffekt von synthetischem Angiotensin II bei primär chronischer Nebennierenrindeninsuffizienz (M. Addison)